BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1036 related articles for article (PubMed ID: 16423459)

  • 1. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
    Agrawal AK; Chaturvedi RK; Shukla S; Seth K; Chauhan S; Ahmad A; Seth PK
    J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
    Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
    J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.
    Agrawal AK; Shukla S; Chaturvedi RK; Seth K; Srivastava N; Ahmad A; Seth PK
    Neurobiol Dis; 2004 Aug; 16(3):516-26. PubMed ID: 15262263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
    Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies.
    Chaturvedi RK; Agrawal AK; Seth K; Shukla S; Chauhan S; Shukla Y; Sinha C; Seth PK
    Int J Dev Neurosci; 2003 Nov; 21(7):391-400. PubMed ID: 14599485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
    Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
    Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
    Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
    Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
    Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E
    Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.
    Wictorin K; Brundin P; Sauer H; Lindvall O; Björklund A
    J Comp Neurol; 1992 Sep; 323(4):475-94. PubMed ID: 1358925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.